Fall in colorectal cancer death rates attributed to screening

Prof Philippe Autier - International Prevention Research Institute, Lyon, France
Fall in colorectal cancer death rates attributed to screening ( Prof Philippe Autier - International Prevention Research Institute, Lyon, France )
28 Sep 2013

Diabetes linked to increased risk and poorer outcomes in breast and colon cancer

Dr Kirstin De Bruijn - Erasmus University Medical Center, Rotterdam, Netherlands
Diabetes linked to increased risk and poorer outcomes in breast and colon cancer ( Dr Kirstin De Bruijn - Erasmus University Medical Center, Rotterdam, Netherlands )
28 Sep 2013

Association between overall survival and government spending on cancer care

Dr Felipe Ades - Institut Jules Bordet, Brussels, Belgium
Association between overall survival and government spending on cancer care ( Dr Felipe Ades - Institut Jules Bordet, Brussels, Belgium )
28 Sep 2013

Cancer survival in Europe strongly associated with government spend on health care

Dr Felipe Ades - Institut Jules Bordet, Brussels, Belgium
Cancer survival in Europe strongly associated with government spend on health care ( Dr Felipe Ades - Institut Jules Bordet, Brussels, Belgium )
28 Sep 2013

Diabetes causes increased risk of developing and dying from breast and colon cancer

Dr Kirstin De Bruijn - Erasmus University Medical Center, Rotterdam, Netherlands
Diabetes causes increased risk of developing and dying from breast and colon cancer ( Dr Kirstin De Bruijn - Erasmus University Medical Center, Rotterdam, Netherlands )
28 Sep 2013

Evidence that fall in colorectal cancer death rates is attributable to screening programmes

Prof Philippe Autier - International Prevention Research Institute, Lyon, France
Evidence that fall in colorectal cancer death rates is attributable to screening programmes ( Prof Philippe Autier - International Prevention Research Institute, Lyon, France )
28 Sep 2013

ecancerNews Highlights from September 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews Highlights from September 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
24 Sep 2013

ecancerNews Highlights from August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews Highlights from August 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Aug 2013

Developments with PD1 and immunotherapy in melanoma

Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France
Developments with PD1 and immunotherapy in melanoma ( Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France )
19 Jul 2013

Battling therapeutic resistance

Dr Gerald Batist - McGill University, Montreal, Canada
Battling therapeutic resistance ( Dr Gerald Batist - McGill University, Montreal, Canada )
19 Jul 2013

Improving predictability of clinical trial outcomes

Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving predictability of clinical trial outcomes ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
18 Jul 2013

Advances in treatment of triple negative breast cancer

Dr Clifford Hudis - Memorial Sloan-Kettering Cancer Center, New York, USA
Advances in treatment of triple negative breast cancer ( Dr Clifford Hudis - Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jul 2013